GC
Grimes & Company Portfolio holdings
AUM
$3.67B
1-Year Return
12.49%
This Quarter Return
+7.06%
1 Year Return
+12.49%
3 Year Return
+42.9%
5 Year Return
+87.85%
10 Year Return
+203.44%
AUM
$1.56B
AUM Growth
+$124M
(+8.6%)
Cap. Flow
+$32M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
38.06%
Holding
266
New
17
Increased
104
Reduced
89
Closed
14
Top Buys
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$12.8M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$12.4M |
| 3 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
$9.41M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$9.24M |
| 5 |
Packaging Corp of America
PKG
|
$7.31M |
Sector Composition
| 1 | Technology | 11.12% |
| 2 | Healthcare | 7.47% |
| 3 | Industrials | 5.2% |
| 4 | Financials | 5.17% |
| 5 | Communication Services | 3.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Hologic
HOLX
$14.8B
| $231K | 0.01% |
+3,474
| New | +$231K |
|
227
Travelers Companies
TRV
$62.9B
| $227K | 0.01% |
2,097
| – | – |
|
228
BP
BP
$88.4B
| $220K | 0.01% |
12,622
-74
| -0.6% | -$1.29K |
|
229
Costco
COST
$424B
| $219K | 0.01% |
+618
| New | +$219K |
|
230
Vanguard S&P 500 ETF
VOO
$730B
| $216K | 0.01% |
+702
| New | +$216K |
|
231
ARK Genomic Revolution ETF
ARKG
$1.05B
| $214K | 0.01% |
+3,365
| New | +$214K |
|
232
Public Storage
PSA
$51.3B
| $214K | 0.01% |
961
-201
| -17% | -$44.8K |
|
233
iShare MSCI Eurozone ETF
EZU
$7.83B
| $210K | 0.01% |
5,533
| – | – |
|
234
L3Harris
LHX
$51.1B
| $206K | 0.01% |
1,210
| – | – |
|
|
MRNS
235
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $145K | 0.01% |
11,250
+7,125
| +173% | +$91.8K |
|
236
Regions Financial
RF
$24.4B
| $133K | 0.01% |
11,502
| – | – |
|
237
Ironwood Pharmaceuticals
IRWD
$179M
| $126K | 0.01% |
14,007
+2,622
| +23% | +$23.6K |
|
|
CALA
238
DELISTED
Calithera Biosciences, Inc
CALA
| $122K | 0.01% |
1,765
+720
| +69% | +$49.8K |
|
|
LJPC
239
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $102K | 0.01% |
25,270
+1,770
| +8% | +$7.14K |
|
240
Huntington Bancshares
HBAN
$26.1B
| $92K | 0.01% |
10,076
-2,297
| -19% | -$21K |
|
|
AGRX
241
DELISTED
Agile Therapeutics, Inc
AGRX
| $89K | 0.01% |
15
+4
| +36% | +$23.7K |
|
242
ADMA Biologics
ADMA
$4.04B
| $80K | 0.01% |
+33,500
| New | +$80K |
|
243
ASE Group
ASX
$22.4B
| $57K | ﹤0.01% |
13,925
+2,751
| +25% | +$11.3K |
|
244
BioCryst Pharmaceuticals
BCRX
$1.74B
| $52K | ﹤0.01% |
+15,000
| New | +$52K |
|
245
Ribbon Communications
RBBN
$737M
| $39K | ﹤0.01% |
10,030
| – | – |
|
246
Aware
AWRE
$47.3M
| $27K | ﹤0.01% |
+10,117
| New | +$27K |
|
|
ALNA
247
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $17K | ﹤0.01% |
+11,289
| New | +$17K |
|
|
RGLS
248
DELISTED
Regulus Therapeutics
RGLS
| $12K | ﹤0.01% |
2,400
+450
| +23% | +$2.25K |
|
|
AAC
249
DELISTED
AAC Holdings, Inc.
AAC
| $1K | ﹤0.01% |
45,454
-15,000
| -25% | -$330 |
|
250
Alcon
ALC
$39B
| – | – |
-11,258
| Closed | -$645K |
|